Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Health Resources and Services Administration

# AGENCY:

Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS).

# ACTION:

Notices; correction.

# SUMMARY:

                        HRSA published documents in the                         **Federal Register**                         of October 24,                               ( print page 10088)                            2023, and January 5, 2024, concerning updates to the Bright Futures Periodicity Schedule as part of the HRSA-supported preventive services guidelines for infants, children, and adolescents. These documents contained minor errors related to updates to two footnotes, including an error in the text of footnote 15 and an error in the description of footnote 21. These minor corrections align with information provided to the public on the Bright Futures web page and referenced by HRSA in the October 24, 2023,                         **Federal Register**                         notice that sought public comment on the proposed updates to the Bright Futures Periodicity Schedule. These corrections do not change the clinical recommendations in the Bright Futures Periodicity Schedule or the associated requirement for certain group health plans and health insurance issuers to provide coverage without cost-sharing under section 2713 of the Public Health Service Act.                    

# FOR FURTHER INFORMATION CONTACT:

                        Savannah Kidd, M.S. MFT, Sr. Public Health Advisor, Division of Child, Adolescent and Family Health, Maternal and Child Health Bureau, HRSA, telephone: (301) 287-2601, email:                         *SKidd@hrsa.gov.*

# SUPPLEMENTARY INFORMATION:

## Correction

                    In the                     **Federal Register**                     of January 5, 2024, FR Doc. 2024-00024, on page 790, column 3, paragraph 2, correct the text of updated footnote 15 to read as follows: “A recommended tool to assess use of alcohol, tobacco and nicotine, and marijuana and other substances, including opioids, is available at                     *http://crafft.org.*                    ” The document incorrectly omitted the phrase, “and other substances, including opioids,” in this sentence.                

                    In the                     **Federal Register**                     of January 5, 2024, FR Doc. 2024-00024, on page 790, column 3, paragraph 3, correct the description of the update to footnote 21 to read as follows: “This updated reference aligns with the Bright Futures recommendation for universal bilirubin screening for all newborn infants between 24 and 48 hours after birth.” The document incorrectly included the phrase “between 24 and 28 hours after birth” in this sentence.                

                    In the                     **Federal Register**                     of October 24, 2023, FR Doc. 2023-23396, on page 73035, column 3, paragraph 3, correct the description of the proposed update to footnote 21 to read as follows: “This reference aligns with the Bright Futures recommendation for universal bilirubin screening for all newborn infants between 24 and 48 hours after birth.” The document incorrectly included the phrase “between 24 and 28 hours after birth.”                

Maria G. Button,

Director, Executive Secretariat.

[FR Doc. 2024-02959 Filed 2-12-24; 8:45 am]

BILLING CODE 4165-15-P